Sign up for our free daily newsletter


Get the latest news and some fun stuff
in your inbox every day

Get slim

Vestact clients have been accumulating Eli Lilly shares, on our recommendation. Their weight-loss drug Zepbound will soon be supported by medical aids around the world. Slimmer people have much better health and longer life-expectancy, and go on paying their premiums. We expect that half of the world's adults will be on GLP-1 treatments in time.

A client said to me "An investment in Eli Lilly sounds great, thank you. Such a pity society invests in these kinds of developments when a good diet and exercise does it for free!"

I replied, "Yes, ideally that would be the case, but most people find it very hard to avoid delicious, high-calorie food. Consider the way people react when presented with a buffet at a hotel?"

As for exercise, many people would rather plonk themselves on a couch. At least to start with, exercising is painful. Some refuse to move for weirder reasons, like sweating disturbing their clothing and cosmetic routine.

All things considered, if an ongoing prescription (with no or very limited side effects) helps people get slim, this seems like a win for humanity.


Other recommended stocks     Other stories about LLY